nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.0168	0.0416	CcSEcCtD
Etoricoxib—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0166	0.041	CcSEcCtD
Etoricoxib—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00951	0.0235	CcSEcCtD
Etoricoxib—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00938	0.0232	CcSEcCtD
Etoricoxib—Vemurafenib—ALB—type 1 diabetes mellitus	0.00905	0.478	CrCbGaD
Etoricoxib—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00789	0.0195	CcSEcCtD
Etoricoxib—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00785	0.0194	CcSEcCtD
Etoricoxib—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00685	0.0169	CcSEcCtD
Etoricoxib—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00675	0.0167	CcSEcCtD
Etoricoxib—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.0064	0.0158	CcSEcCtD
Etoricoxib—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00638	0.0158	CcSEcCtD
Etoricoxib—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00627	0.0155	CcSEcCtD
Etoricoxib—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00619	0.0153	CcSEcCtD
Etoricoxib—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00569	0.0141	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00554	0.0137	CcSEcCtD
Etoricoxib—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00548	0.0136	CcSEcCtD
Etoricoxib—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00546	0.0135	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00546	0.0135	CcSEcCtD
Etoricoxib—Gastritis—Ramipril—type 1 diabetes mellitus	0.00537	0.0133	CcSEcCtD
Etoricoxib—Celecoxib—ALB—type 1 diabetes mellitus	0.00532	0.281	CrCbGaD
Etoricoxib—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00516	0.0128	CcSEcCtD
Etoricoxib—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00514	0.0127	CcSEcCtD
Etoricoxib—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00511	0.0126	CcSEcCtD
Etoricoxib—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00504	0.0125	CcSEcCtD
Etoricoxib—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00503	0.0124	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00487	0.0121	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00479	0.0118	CcSEcCtD
Etoricoxib—Weight increased—Ramipril—type 1 diabetes mellitus	0.00477	0.0118	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00464	0.0115	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00461	0.0114	CcSEcCtD
Etoricoxib—Renal failure—Ramipril—type 1 diabetes mellitus	0.0046	0.0114	CcSEcCtD
Etoricoxib—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00458	0.0113	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00458	0.0113	CcSEcCtD
Etoricoxib—Vismodegib—ALB—type 1 diabetes mellitus	0.00456	0.241	CrCbGaD
Etoricoxib—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00456	0.0113	CcSEcCtD
Etoricoxib—Jaundice—Ramipril—type 1 diabetes mellitus	0.00456	0.0113	CcSEcCtD
Etoricoxib—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00455	0.0112	CcSEcCtD
Etoricoxib—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00455	0.0112	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00442	0.0109	CcSEcCtD
Etoricoxib—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00441	0.0109	CcSEcCtD
Etoricoxib—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00439	0.0109	CcSEcCtD
Etoricoxib—Hepatitis—Ramipril—type 1 diabetes mellitus	0.0042	0.0104	CcSEcCtD
Etoricoxib—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00414	0.0102	CcSEcCtD
Etoricoxib—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00413	0.0102	CcSEcCtD
Etoricoxib—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00405	0.01	CcSEcCtD
Etoricoxib—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00397	0.00982	CcSEcCtD
Etoricoxib—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00391	0.00969	CcSEcCtD
Etoricoxib—Flushing—Ramipril—type 1 diabetes mellitus	0.0039	0.00964	CcSEcCtD
Etoricoxib—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00379	0.00938	CcSEcCtD
Etoricoxib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00378	0.00936	CcSEcCtD
Etoricoxib—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00375	0.00928	CcSEcCtD
Etoricoxib—Alopecia—Ramipril—type 1 diabetes mellitus	0.00371	0.00918	CcSEcCtD
Etoricoxib—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00368	0.0091	CcSEcCtD
Etoricoxib—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00365	0.00904	CcSEcCtD
Etoricoxib—Erythema—Ramipril—type 1 diabetes mellitus	0.00365	0.00904	CcSEcCtD
Etoricoxib—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00358	0.00886	CcSEcCtD
Etoricoxib—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00351	0.00869	CcSEcCtD
Etoricoxib—Tremor—Ramipril—type 1 diabetes mellitus	0.00342	0.00847	CcSEcCtD
Etoricoxib—Agitation—Ramipril—type 1 diabetes mellitus	0.00336	0.00831	CcSEcCtD
Etoricoxib—Angioedema—Ramipril—type 1 diabetes mellitus	0.00334	0.00826	CcSEcCtD
Etoricoxib—Palpitations—Ramipril—type 1 diabetes mellitus	0.00323	0.00799	CcSEcCtD
Etoricoxib—Cough—Ramipril—type 1 diabetes mellitus	0.00319	0.00789	CcSEcCtD
Etoricoxib—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00311	0.0077	CcSEcCtD
Etoricoxib—Chest pain—Ramipril—type 1 diabetes mellitus	0.00311	0.0077	CcSEcCtD
Etoricoxib—Anxiety—Ramipril—type 1 diabetes mellitus	0.0031	0.00767	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00309	0.00765	CcSEcCtD
Etoricoxib—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00304	0.00753	CcSEcCtD
Etoricoxib—Confusional state—Ramipril—type 1 diabetes mellitus	0.00301	0.00744	CcSEcCtD
Etoricoxib—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00298	0.00738	CcSEcCtD
Etoricoxib—Oedema—Ramipril—type 1 diabetes mellitus	0.00298	0.00738	CcSEcCtD
Etoricoxib—Shock—Ramipril—type 1 diabetes mellitus	0.00293	0.00726	CcSEcCtD
Etoricoxib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00293	0.00724	CcSEcCtD
Etoricoxib—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00292	0.00723	CcSEcCtD
Etoricoxib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0029	0.00717	CcSEcCtD
Etoricoxib—Anorexia—Ramipril—type 1 diabetes mellitus	0.00284	0.00703	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00272	0.00672	CcSEcCtD
Etoricoxib—Insomnia—Ramipril—type 1 diabetes mellitus	0.0027	0.00668	CcSEcCtD
Etoricoxib—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00266	0.00658	CcSEcCtD
Etoricoxib—Somnolence—Ramipril—type 1 diabetes mellitus	0.00265	0.00656	CcSEcCtD
Etoricoxib—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00263	0.0065	CcSEcCtD
Etoricoxib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00259	0.00642	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00258	0.00637	CcSEcCtD
Etoricoxib—Fatigue—Ramipril—type 1 diabetes mellitus	0.00257	0.00636	CcSEcCtD
Etoricoxib—Constipation—Ramipril—type 1 diabetes mellitus	0.00255	0.00631	CcSEcCtD
Etoricoxib—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00246	0.00608	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00244	0.00603	CcSEcCtD
Etoricoxib—Urticaria—Ramipril—type 1 diabetes mellitus	0.00237	0.00586	CcSEcCtD
Etoricoxib—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00236	0.00583	CcSEcCtD
Etoricoxib—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.0022	0.00544	CcSEcCtD
Etoricoxib—Asthenia—Ramipril—type 1 diabetes mellitus	0.00214	0.0053	CcSEcCtD
Etoricoxib—Pruritus—Ramipril—type 1 diabetes mellitus	0.00211	0.00522	CcSEcCtD
Etoricoxib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00204	0.00505	CcSEcCtD
Etoricoxib—Dizziness—Ramipril—type 1 diabetes mellitus	0.00197	0.00488	CcSEcCtD
Etoricoxib—Vomiting—Ramipril—type 1 diabetes mellitus	0.0019	0.00469	CcSEcCtD
Etoricoxib—Rash—Ramipril—type 1 diabetes mellitus	0.00188	0.00465	CcSEcCtD
Etoricoxib—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00188	0.00465	CcSEcCtD
Etoricoxib—Headache—Ramipril—type 1 diabetes mellitus	0.00187	0.00462	CcSEcCtD
Etoricoxib—Nausea—Ramipril—type 1 diabetes mellitus	0.00177	0.00438	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—type 1 diabetes mellitus	0.000368	0.000638	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	0.000366	0.000634	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	0.000365	0.000632	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—type 1 diabetes mellitus	0.000364	0.000632	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—type 1 diabetes mellitus	0.000364	0.000631	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—type 1 diabetes mellitus	0.000362	0.000628	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IGF2—type 1 diabetes mellitus	0.000361	0.000625	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—VAV1—type 1 diabetes mellitus	0.000358	0.000621	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000354	0.000613	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—type 1 diabetes mellitus	0.000347	0.000601	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	0.000345	0.000598	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—type 1 diabetes mellitus	0.000342	0.000593	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000338	0.000587	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—TYK2—type 1 diabetes mellitus	0.000338	0.000585	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.000336	0.000582	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000335	0.000581	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000335	0.000581	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—STAT3—type 1 diabetes mellitus	0.000333	0.000578	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000329	0.00057	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—type 1 diabetes mellitus	0.000326	0.000566	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000322	0.000559	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—LGALS3—type 1 diabetes mellitus	0.00032	0.000554	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000319	0.000553	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000319	0.000553	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000317	0.000549	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—type 1 diabetes mellitus	0.000313	0.000543	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD86—type 1 diabetes mellitus	0.000313	0.000542	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—G6PC2—type 1 diabetes mellitus	0.000311	0.000539	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.000307	0.000533	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ITPR3—type 1 diabetes mellitus	0.000305	0.000529	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2RA—type 1 diabetes mellitus	0.000303	0.000526	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFIH1—type 1 diabetes mellitus	0.000303	0.000525	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000297	0.000514	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—type 1 diabetes mellitus	0.000294	0.00051	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HLA-B—type 1 diabetes mellitus	0.000292	0.000505	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—type 1 diabetes mellitus	0.000291	0.000504	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000283	0.00049	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—ERBB3—type 1 diabetes mellitus	0.000282	0.000489	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.000281	0.000488	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	0.000279	0.000484	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	0.000279	0.000483	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	0.000277	0.00048	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTPN2—type 1 diabetes mellitus	0.000277	0.00048	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—B2M—type 1 diabetes mellitus	0.000274	0.000475	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CDK4—type 1 diabetes mellitus	0.000274	0.000475	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.000271	0.000469	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	0.000265	0.00046	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NOS2—type 1 diabetes mellitus	0.000261	0.000453	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HBA2—type 1 diabetes mellitus	0.000261	0.000452	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000261	0.000452	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CRP—type 1 diabetes mellitus	0.000258	0.000447	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—STAT3—type 1 diabetes mellitus	0.000252	0.000437	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000248	0.00043	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000245	0.000425	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—INS—type 1 diabetes mellitus	0.000244	0.000423	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000242	0.00042	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-E—type 1 diabetes mellitus	0.000238	0.000413	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000236	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000236	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000234	0.000405	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000234	0.000405	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—type 1 diabetes mellitus	0.000233	0.000404	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IGF1—type 1 diabetes mellitus	0.000231	0.000401	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00023	0.000399	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTLA4—type 1 diabetes mellitus	0.00023	0.000398	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD80—type 1 diabetes mellitus	0.000228	0.000395	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000226	0.000392	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00022	0.000381	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ALB—type 1 diabetes mellitus	0.000219	0.00038	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD79A—type 1 diabetes mellitus	0.000219	0.00038	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000218	0.000378	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PRKCQ—type 1 diabetes mellitus	0.000215	0.000373	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000215	0.000372	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000215	0.000372	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	0.000214	0.000371	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000213	0.000369	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NOS3—type 1 diabetes mellitus	0.00021	0.000364	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00021	0.000363	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—VAV1—type 1 diabetes mellitus	0.000209	0.000362	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000202	0.00035	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	0.000201	0.000349	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000197	0.000342	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000193	0.000334	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.00019	0.000329	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	0.000189	0.000328	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000189	0.000328	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	0.000188	0.000327	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000186	0.000322	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000185	0.000321	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000185	0.00032	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000185	0.00032	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000184	0.000318	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—VDR—type 1 diabetes mellitus	0.000183	0.000316	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD86—type 1 diabetes mellitus	0.000182	0.000316	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.00018	0.000313	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	0.00018	0.000312	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000179	0.000311	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000179	0.00031	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40LG—type 1 diabetes mellitus	0.000179	0.000309	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—type 1 diabetes mellitus	0.000178	0.000308	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—type 1 diabetes mellitus	0.000177	0.000306	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—type 1 diabetes mellitus	0.000176	0.000305	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—type 1 diabetes mellitus	0.000174	0.000302	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000174	0.000302	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000173	0.000299	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-B—type 1 diabetes mellitus	0.00017	0.000294	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOC3—type 1 diabetes mellitus	0.000168	0.000292	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IAPP—type 1 diabetes mellitus	0.000168	0.000292	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000168	0.000291	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000165	0.000286	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ERBB3—type 1 diabetes mellitus	0.000164	0.000285	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000164	0.000284	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SST—type 1 diabetes mellitus	0.000162	0.000281	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—B2M—type 1 diabetes mellitus	0.000162	0.00028	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000161	0.00028	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2RA—type 1 diabetes mellitus	0.000159	0.000276	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-A—type 1 diabetes mellitus	0.000157	0.000273	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000157	0.000272	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—STAT3—type 1 diabetes mellitus	0.000153	0.000265	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000151	0.000262	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000151	0.000261	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—type 1 diabetes mellitus	0.00015	0.00026	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.00015	0.000259	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000147	0.000256	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000144	0.00025	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000144	0.000249	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000142	0.000246	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	0.000142	0.000246	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	0.000141	0.000244	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000139	0.000241	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—type 1 diabetes mellitus	0.000139	0.00024	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000138	0.00024	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS1—type 1 diabetes mellitus	0.000135	0.000235	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000135	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000135	0.000233	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HBA1—type 1 diabetes mellitus	0.000134	0.000231	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD80—type 1 diabetes mellitus	0.000133	0.00023	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOC3—type 1 diabetes mellitus	0.000133	0.00023	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—type 1 diabetes mellitus	0.000132	0.000229	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTT1—type 1 diabetes mellitus	0.00013	0.000226	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00013	0.000225	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000128	0.000222	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000128	0.000221	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	0.000127	0.00022	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—VAV1—type 1 diabetes mellitus	0.000123	0.000213	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—type 1 diabetes mellitus	0.000123	0.000212	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000122	0.000212	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000121	0.00021	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000119	0.000207	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000118	0.000205	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000118	0.000204	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000114	0.000197	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TYK2—type 1 diabetes mellitus	0.000112	0.000194	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000112	0.000194	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	0.00011	0.000191	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	0.000109	0.00019	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD86—type 1 diabetes mellitus	0.000107	0.000186	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—type 1 diabetes mellitus	0.000107	0.000185	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000106	0.000184	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—type 1 diabetes mellitus	0.000105	0.000182	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000104	0.000181	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GCG—type 1 diabetes mellitus	0.000104	0.00018	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	0.000103	0.000179	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000103	0.000178	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	0.000102	0.000177	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—type 1 diabetes mellitus	0.000101	0.000176	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000101	0.000175	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000101	0.000175	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	0.000101	0.000174	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	9.98e-05	0.000173	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	9.87e-05	0.000171	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	9.68e-05	0.000168	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—type 1 diabetes mellitus	9.52e-05	0.000165	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	9.48e-05	0.000164	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	9.42e-05	0.000163	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—type 1 diabetes mellitus	9.42e-05	0.000163	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	9.39e-05	0.000163	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—type 1 diabetes mellitus	9.36e-05	0.000162	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	9.34e-05	0.000162	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	9.34e-05	0.000162	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—type 1 diabetes mellitus	9.33e-05	0.000162	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	9.28e-05	0.000161	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	9.27e-05	0.000161	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	9.25e-05	0.00016	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	9.17e-05	0.000159	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CAT—type 1 diabetes mellitus	8.79e-05	0.000152	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD80—type 1 diabetes mellitus	8.59e-05	0.000149	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	8.53e-05	0.000148	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	8.45e-05	0.000146	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—INS—type 1 diabetes mellitus	8.11e-05	0.000141	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—type 1 diabetes mellitus	8.07e-05	0.00014	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	8.03e-05	0.000139	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	8.01e-05	0.000139	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	7.98e-05	0.000138	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—type 1 diabetes mellitus	7.85e-05	0.000136	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.85e-05	0.000136	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	7.84e-05	0.000136	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD80—type 1 diabetes mellitus	7.83e-05	0.000136	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	7.8e-05	0.000135	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—INS—type 1 diabetes mellitus	7.4e-05	0.000128	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	7.37e-05	0.000128	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	7.31e-05	0.000127	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.25e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.22e-05	0.000125	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—type 1 diabetes mellitus	7.14e-05	0.000124	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.12e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	6.78e-05	0.000118	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TYK2—type 1 diabetes mellitus	6.61e-05	0.000115	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	6.58e-05	0.000114	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—type 1 diabetes mellitus	6.49e-05	0.000113	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	6.24e-05	0.000108	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	6.24e-05	0.000108	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—INS—type 1 diabetes mellitus	6.2e-05	0.000107	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	6.2e-05	0.000107	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	6.18e-05	0.000107	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	6.16e-05	0.000107	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	6.05e-05	0.000105	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.04e-05	0.000105	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—type 1 diabetes mellitus	6.03e-05	0.000105	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—type 1 diabetes mellitus	5.98e-05	0.000104	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	5.84e-05	0.000101	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	5.68e-05	9.85e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—type 1 diabetes mellitus	5.48e-05	9.51e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	5.44e-05	9.42e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	5.35e-05	9.27e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	5.28e-05	9.16e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	5.12e-05	8.87e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.08e-05	8.8e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	4.82e-05	8.35e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—type 1 diabetes mellitus	4.63e-05	8.03e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.61e-05	8e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	4.5e-05	7.8e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—type 1 diabetes mellitus	4.21e-05	7.29e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	4.14e-05	7.18e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	4.13e-05	7.15e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	4.11e-05	7.12e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	4.08e-05	7.07e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	3.95e-05	6.84e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.8e-05	6.58e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	3.76e-05	6.52e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3.63e-05	6.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	3.6e-05	6.24e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—type 1 diabetes mellitus	3.55e-05	6.15e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.51e-05	6.08e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—type 1 diabetes mellitus	3.23e-05	5.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	3.22e-05	5.57e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	3.08e-05	5.33e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.71e-05	4.69e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.48e-05	4.3e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.37e-05	4.12e-05	CbGpPWpGaD
